SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mission Bio, a leader in single-cell multiomic solutions for precision medicine, announced today new data generated by clinical researchers from leading ...

New Chair brings extensive financial and life sciences experience with industry-leading companies SOUTH SAN FRANCISCO, Calif., March 17, 2022 /PRNewswire/ -- Mission Bio, Inc., the pioneer in ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mission Bio, a leader in single-cell multi-omic solutions for precision medicine, announced today initial results from the National Institute of Standards ...

Mission Bio partnered with Abiosciences to co-develop bioinformatics packages for translational and clinical research applications in hematological cancers in China. The goal is to combine Mission Bio ...

Physician-scientist with experience spanning biomarker development and regulatory submissions joins to expand Tapestri’s reach to guide therapeutic insights Mission Bio, a leader in single-cell ...

The new Tapestri® v3 chemistry increases the number of cells captured per sample by up to four times compared to the prior chemistry, a notable enhancement. With enhanced cell capture, the Tapestri® ...

GUANGZHOU, China and SOUTH SAN FRANCISCO, Calif., Dec. 30, 2021 /PRNewswire/ -- Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, has signed an agreement with ...

Mission Bio Inc. released its Tapestri single-cell minimal residual disease (MRD) assay for acute myeloid leukemia (AML) on September 26, with the goal of enabling greater personalization of care for ...

Servier and leading academic labs presenting key clinical findings powered by Tapestri ® likely to impact patient treatment, among 12 groups sharing data at the conference Mission Bio will present on ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Yan Zhang, CEO of Mission Bio Inc., spoke to us about the ...